A detailed history of Braidwell LP transactions in Immatics N.V. stock. As of the latest transaction made, Braidwell LP holds 1,647,565 shares of IMTX stock, worth $13.5 Million. This represents 0.53% of its overall portfolio holdings.

Number of Shares
1,647,565
Holding current value
$13.5 Million
% of portfolio
0.53%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$10.93 - $12.92 $18 Million - $21.3 Million
1,647,565 New
1,647,565 $18.8 Billion
Q1 2023

May 15, 2023

SELL
$6.74 - $9.44 $6.25 Million - $8.76 Million
-927,765 Reduced 74.22%
322,287 $2.22 Billion
Q4 2022

Feb 14, 2023

BUY
$8.05 - $11.58 $10.1 Million - $14.5 Million
1,250,052 New
1,250,052 $10.9 Billion

Others Institutions Holding IMTX

About Immatics N.V.


  • Ticker IMTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 76,227,000
  • Market Cap $623M
  • Description
  • Immatics N.V., a clinical-stage biopharmaceutical company, focuses on the discovery and development of T cell receptor (TCR) based immunotherapies for the treatment of cancer in the United States. The company is developing targeted immunotherapies with a focus on treating solid tumors through two distinct treatment modalities, such as adoptive c...
More about IMTX
Track This Portfolio

Track Braidwell LP Portfolio

Follow Braidwell LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Braidwell LP, based on Form 13F filings with the SEC.

News

Stay updated on Braidwell LP with notifications on news.